Back to Companies
Lineage Cell Therapeutics, Inc.
LCTXNYSECIK: 0000876343
Over the 8 most recent insider filings, Lineage Cell Therapeutics, Inc. (LCTX) has seen activity from 7 distinct insiders — all of them on the buy side. The activity is heavily weighted toward buying: $24.4K bought versus $0 sold, a net purchase of $24.4K. Russell Angus C. is the most active by dollar volume, and the single largest transaction was $162.5K by Russell Angus C.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$837.5K
Purchases
$24.4K
Sales
$0
Unique Insiders
7
Recent Insider Trades
8 loaded
| Jul 2 | LCTX Lineage Cell Therapeutics, Inc. | Russell Angus C. | Insider | Award | $162.5K |
| Jul 2 | LCTX Lineage Cell Therapeutics, Inc. | Bradsher Neal C | Director, 10% Owner | Award | $162.5K |
| Jul 2 | LCTX Lineage Cell Therapeutics, Inc. | Jayasuriya Anula | Insider | Award | $162.5K |
| Jul 2 | LCTX Lineage Cell Therapeutics, Inc. | ANDREWS DEBORAH J | Insider | Award | $162.5K |
| Jul 2 | LCTX Lineage Cell Therapeutics, Inc. | Mulroy Michael H. | Insider | Award | $162.5K |
| Mar 12 | LCTX Lineage Cell Therapeutics, Inc. | Culley Brian M | Insider | Buy | $24.4K |
| Dec 19 | LCTX Lineage Cell Therapeutics, Inc. | Samuel George A. III | Insider | Grant | $109 |
| Dec 19 | LCTX Lineage Cell Therapeutics, Inc. | Culley Brian M | Insider | Grant | $561 |
8 filings